赛诺菲已达成初步和解，以了结药品批发商长期以来提出的指控，即这家制药公司利用不当的专利登记来压制其糖尿病治疗药物来得时（Lantus）的竞争。
Sanofi has reached a tentative settlement to resolve long-running claims by drug wholesalers that the pharmaceutical company used an improper patent listing to suppress competition to its diabetes treatment Lantus.